Summary
- The menopause industry is worth billions globally, but lacks substantial scientific backing for its claims.
- Increased awareness has led to more women seeking hormone replacement therapy (HRT) prescriptions.
- Lack of long-term data on HRT and alternative management options raises questions about over-medicalization of menopause.
- Media and private practices may push medical interventions like HRT without presenting a full range of options.